Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • News
    • Implants / Devices
    • IIT-Roorkee develops...

    IIT-Roorkee develops bioresorbable, economical ortho implants to heal bone fractures

    Farhat NasimWritten by Farhat Nasim Published On 2019-12-28T09:40:26+05:30  |  Updated On 28 Dec 2019 9:40 AM IST

    The current therapeutic strategies for healing bone defects commonly suffer from the occurrence of bacterial contamination on the graft, resulting in non-union in the segmental bone defects and the requirement for secondary surgery to remove or sterilize the primary graft, according to the team at IIT, Roorkee.


    New Delhi: Researchers at the Indian Institute of Technology (IIT), Roorkee have synthesised bioresorbable and economical orthopaedic implants for healing bone fractures.


    The current therapeutic strategies for healing bone defects commonly suffer from the occurrence of bacterial contamination on the graft, resulting in non-union in the segmental bone defects and the requirement for secondary surgery to remove or sterilize the primary graft, according to the team at IIT, Roorkee.


    "The current clinical grafting methods suffer from post-operative infections and the unwarranted adhesion between the healing bone and the adjacent soft tissues. A membrane with enhanced anti-bacterial efficacy would fight-off any post-operative bacterial infections on their own without any secondary interventions or surgeries, thus helping reduce the cost and the healing time," said Sarim Khan, the first author on the two studies.


    "A mechanically strong membrane would provide a barrier for maintaining the original shape of the bone and avert any post-operative attachment between the bone and the surrounding soft tissues. These two associated complications with the current standards inspired these studies," he said.


    Also Read: Cost of orthopaedic knee implants will not be allowed to rise beyond 10 per cent: NPPA


    A membrane with enhanced anti-bacterial efficacy, mechanical strength and osteoconductivity would represent an improvement in the therapeutic strategy for guided bone regeneration.


    Khan said research has shown that 20 pc of women aged over 50 in India suffer from osteoporosis and that such a low-cost alternative would make the treatment affordable for healing fractures due to osteoporosis in women.


    The research team is currently planning on working with industries to run clinical trials in order to establish its commercial use, he added.


    Also Read: Price cap of Orthopaedic Knee Implants led to boosted sales, says NPPA

    bone defectsbone fracturebone regenerationgraftingIITIIT Roorkeeimplantsortho implantsosteoporosis
    Source : PTI

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    Farhat Nasim
    Farhat Nasim

      Farhat Nasim joined Medical Dialogue an Editor for the Business Section in 2017. She Covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She is a graduate of St.Xavier’s College Ranchi. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751 To know about our editorial team click here

      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok